ChemoMetec AS (OCSE:CHEMM) EPS (Basic): kr10.17 (TTM As of Dec. 2025)


OCSE:CHEMM ChemoMetec AS OCSE:CHEMM
99 GF Score
Price kr369.20
GF Value kr523.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is ChemoMetec AS EPS (Basic)?

ChemoMetec AS OCSE:CHEMM +0.76% 99 EPS (Basic) is kr10.17 as of Dec. 2025. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ChemoMetec AS's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was kr5.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was kr10.17.

ChemoMetec AS's EPS (Diluted) for the six months ended in Dec. 2025 was kr5.40. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr10.17.

ChemoMetec AS's EPS without NRI for the six months ended in Dec. 2025 was kr5.40. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 10.17.

During the past 12 months, ChemoMetec AS's average EPS without NRIGrowth Rate was 4.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 22.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 42.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, ChemoMetec AS's highest 3-Year average EPS without NRI Growth Rate was 223.80% per year. The lowest was -89.90% per year. And the median was 50.50% per year.

ChemoMetec AS  (OCSE:CHEMM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

ChemoMetec AS EPS (Basic) Related Terms

ChemoMetec AS EPS (Basic) Historical Data

* Premium members only.

The historical data trend for ChemoMetec AS's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ChemoMetec AS EPS (Basic) Chart

ChemoMetec AS Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.08 9.16 10.27 7.83 10.71

ChemoMetec AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.05 3.78 5.94 4.77 5.40
OCSE:CHEMM
99GF Score
ChemoMetec AS OCSE:CHEMM
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ChemoMetec AS EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

ChemoMetec AS's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(186.405-0)/17.402
=10.71

ChemoMetec AS's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(93.975-0)/17.403
=5.40

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr10.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of kr10.17 mean?
ChemoMetec AS (OCSE:CHEMM) has a EPS (Basic) of kr10.17 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on ChemoMetec AS and its competitors.
Is ChemoMetec AS's EPS (Basic) too high?
ChemoMetec AS's current EPS (Basic) is kr10.17. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's EPS (Basic) compare to ABT and SYK?
ChemoMetec AS's EPS (Basic) of kr10.17 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on ChemoMetec AS and its competitors. ChemoMetec AS's current EPS (Basic) is kr10.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.21, compared to a current price of kr369.20 — trading 29.4% below its estimated fair value. The current EPS (Basic) is kr10.17. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current EPS (Basic) is kr10.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?

Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued. The current stock price of kr369.20 is trading 29.4% below its estimated GF Value™ of kr523.21. GuruFocus considers ChemoMetec AS to be Modestly Undervalued.

Key valuation signals for OCSE:CHEMM:

  • EPS (Basic): kr10.17
  • GF Value™: kr523.21 vs. price of kr369.20 (29.4% below fair value)
  • GF Score™: 99/100 with 2 warning signs

No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ChemoMetec AS Business Description

Other Exchanges CHEMMc:UK0DZ0:UKCHY:Germany
Address Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score

Get the complete analysis for OCSE:CHEMM

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr369.20
Price
kr523.21
GF Value